Association for Molecular Pathology                       
May 2009, Volume 15, Number 2                                              
      >>Download this Newsletter as a PDF

Inside this Issue

Front Page
President's Message
Committee Reports
• Clinical Practice Committee
• Economic Affairs Committee
• Membership & Professional
  Development Committee
• Nominating Committee
• Professional Relations Committee
• Program Committee
• Publications Committee
• Training & Education Committee
Subdivision Reports
• Genetics
• Hematopathology
• Infectious Diseases
• Solid Tumors
Special Features
• AMP Leadership Award

• Member Survey Report
• Web Editorial Board Report
• Show Me the Money!
• Announcements
• Career Opportunities
• Meetings and Upcoming Events
2009 AMP Officers and Appointees
This Newsletter is published three times a year by the Association for Molecular Pathology (AMP). The contents of the Newsletter may not be reproduced for distribution of any kind without the express, specific, written permission of the association. AMP will not publish and/or post material that is primarily commercial in nature. Articles, announcements, and news briefs are welcome and will be edited and published at the discretion of the editors.


Teresita Cuyegkeng Redondo, MD

Marlene Sabbath-Solitare, PhD

Production Editor:
Alta E Wallington

Association for Molecular Pathology Logo
Association for Molecular Pathology
9650 Rockville Pike
Bethesda, MD 20814-3993
Tel:  301-634-7939
Fax: 301-634-7990

President's Message
Jan A. Nowak, MD, PhD

Musing about AMP’s fifteenth year, I looked back to the Tenth Anniversary Issue of the AMP Newsletter (Vol 10, Number 4, 2004). Amidst the many reminiscences in that issue, I focused on then President Angie Caliendo’s message.  “Today,” she wrote, “it is impossible to imagine the practice of medicine without molecular methods.”  The trendy catch phrases of today touting a new world of personalized medicine, with targeted therapies directed to specific patients identified with laser directed precision by pharmacogenomic testing using companion diagnostics were yet to be hatched, but as an organization we knew that the future of medicine lay with molecular biology.
>>Read the Article

AMP Infiltrates the Halls of Congress
Representatives from AMP are actively engaged with Congressional members regarding input on health reform, oversight and reimbursement of genetic tests, as well as DTC genetic testing. Of particular interest were DNA patents as Congress was not aware that the human genome was being patented. See Jean Amos Wilson’s Professional Relations Committee Report

AMP Joins the American Civil Liberties Union to Challenge the Constitutionality of Gene Patents
>>Read the Press Release

2009 Recipient of AMP Leadership Award
Debra G. B. Leonard, MD, PhDThe members of the Nominating Committee and AMP Council are pleased to announce Debra G. B. Leonard, MD, PhD as the recipient of the prestigious AMP Leadership Award for 2009.  Dr. Leonard has held a faculty position as Professor of Pathology and Laboratory Medicine at the Weill Medical College of Cornell University and has served as Vice-Chairman for Laboratory Medicine and Director of Clinical Laboratories at New York-Presbyterian Hospital, Weill-Cornell campus since 2004. >>Read the Article

AMP 2009 Annual Meeting & Exhibits
The Association for Molecular Pathology (AMP) 15th Annual Meeting and Exhibits opens November 19-22, 2009, at the Gaylord Palms Resort & Convention Center, Kissimmee, (Orlando) Florida.
>>AMP 2009 Annual Meeting Program.

Abstract Submission Deadline:
June 2, 2009

Early (Reduced) Registration Deadline: September 14, 2009

Advance Registration Deadline:
October 14, 2009

Housing Reservations (Reduced Meeting Rate) Deadline:
October 18, 2009